Although we did not observe changes in cholesterol levels in the SmarcAL1 KO mice (see Discussion), the downregulation of LDLR expression aligns with the hypercholesterolemia observed in SIOD patients. This evidence concerns the gene LDLR and Schimke immuno-osseous dysplasia.